GOLDENWELL BIOTECH, INC. — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$55

Net Income/Loss (FY2025)

-$296.5K

Total Assets (FY2025)

$36.1K

Total Equity (FY2025)

-$343.7K

Cash Flows from Operating Activities (FY2025)

-$22.6K

Source: GOLDENWELL BIOTECH, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.